JYB1907
/ Jemincare
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 24, 2025
Safety, efficacy, and pharmacokinetic (PK) results from a phase Ⅰ first-in-human study of JYB1907 in patients with advanced solid tumors [WITHDRAWN]
(ESMO 2025)
- No abstract available
Clinical • First-in-human • Metastases • P1 data • PK/PD data • Oncology • Solid Tumor
June 27, 2023
JYB1907 in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Jemincare | Trial primary completion date: Sep 2023 ➔ Sep 2024
Metastases • Trial primary completion date • Oncology • Solid Tumor
April 20, 2023
JYB1907 in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Jemincare
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1